Sign in
4

Changes in Ownership

InMed Pharmaceuticals Inc. Filed Acc 0001213900-22-080967

Options or other derivatives

  • President & CEO acquired 15,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
ADAMS ERIC A President & CEO 2022-12-16 Grant or award · Employee Stock Option (Right to Buy) +15,000 28,502 D
Loading xslF345X03/ownership.xml…